Similarly, in vitro treatment of T98G glioma cells with ciglitazone (f), 15d-PGJ2 (j) or ATRA (n) cultured in NBM+B27 with EGF+FGF resulted in 44, 65 and 78% inhibition of proliferation, respectively. Here, EGF is linked to central nervous system cancer.